Injeq Oy of Tampere at MEDICA 2017 in Düsseldorf -- MEDICA Trade Fair

Injeq Oy

Hermiankatu 22, 33720 Tampere

Telephone +358 40 7516763

This company is co-exhibitor of
Finpro Oy

Hall map

MEDICA 2017 hall map (Hall 15): stand E55

Fairground map

MEDICA 2017 fairground map: Hall 15

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.09  Hospital and Care equipment
  • 01.09.05  Neonatal care equipment

Our products

Product category: Neonatal care equipment

Injeq IQ-Needle

Injeq IQ-Needle is a hypodermic needle with a stylet. Injeq IQ-Needle is available in different sizes and it can be applied in variety of punctures.

Injeq IQ-Needle indicated for lumbar puncture is available in sizes

  • 22G length 40mm (1.5")
  • 22G length 90mm (3.5")
  • 27G length 90mm (3.5")

More Less

Product category: Neonatal care equipment

Injeq IQ-Biopsy Needle

Injeq IQ-Biopsy Needle is a single use core biopsy needle designed for use with Injeq IQ-Biopsy Instrument and BZ-300 series analyzer. The IQ-Biopsy System enables physician to receive a notification about tumors at the tip of the needle before taking the biopsy.

The tumor identification complements ultrasound guidance and it helps physician in obtaining the best quality tissue sample. Tumor identification may also provide an early sign about the tumor type which will be later confirmed by pathological analysis. Improved success rates on tissue samples contribute to both hospital economics and quality of life for patients.

Injeq IQ-Biopsy Needle has been in clinical research since May, 2016.

More Less

Product category: Neonatal care equipment

Injeq BZ-301 impedance analyzer

Injeq BZ-301 impedance analyzer is a real-time tissue identification device. The device has been designed for hospital use and it withstands typical cleaning and disinfection practices.

Injeq BZ-301 is easy to use. The OLED display and large text allows observing the output from distance easily. An accompanying audio alert is typically also used to indicate target has been reached.

BZ-301 is a great research device. It can be configured to log operations in clinical research which allows rich post operation off-line analysis.

More Less

About us

Company details

Our mission is driving tissue-identifying bio-impedance needles to
1) Start the transformation of lumbar puncture towards impedance augmented
2) Introduce tissue-identifying biopsy tools for tumors including cancer

How It Works
Injeq has developed bioimpedance based tissue identifying products for medical use.

Tissue identifying Injeq IQ-Needle feels like a high quality spinal needle. Injeq IQ-Needle includes a unique electrode that allows bioimpedance measurement of the tissue in contact with the tip of the needle.

A proprietary low energy measurement signal allows Injeq BZ-301 to analyze the changes in signal caused by the tissue contact, and calculate the impedance in multiple frequency points. The calculation is compared against a statistical tissue model in real-time and a simple text for tissue type is shown to user or an audio alert is made. The measurement is continuous and repeated hundreds of times every second.

In practice the user will enjoy real-time tissue identification in his/her application.

Key attributes of Injeq technology portfolio:

  • Medical grade real-time impedance measurement conforming to IEC 60601 and  IEC 62304
  • Proven real-time tissue identification (in vivo clinical studies)
  • Bi-polar electrode design for space constrained needle tips
  • Statistical tissue models based on proprietary tissue database
  • Parametric configuration of analyzer which allows developing new applications in rapid manner
Real-Time Bio-Impedance Spectroscopy

This image illustrates impedance frequency dependency over time in a continuous measurement session during a spinal puncture. Blue tissue in the end of the time series has been identified as fat and magenta as cerebrospinal fluid. Data source is clinical study.

Injeq has patents issued and pending. The products have been used in two clinical studies and third study is currently in planning phase.

Clinical Research
Clinical research has been on-going since 2014. A Study on spine structures and use of bio-impedance tissue sensing in adult population is currently ongoing. This investigation is performance study by nature and first results have already been published.

Following the research success in adult population a study about Injeq IQ-Needle use among pediatric patients prescribed for a diagnostic spinal fluid sample was started in August 2016.

A clinical study is about identification of liver tumors using bio-impedance core biopsy needle is another parallel research activity. The study was started in June 2016.

According to best practices of the industry also Injeq registers all studies in


More Less